Found: 20
Select item for more details and to access through your institution.
Safety of a C1-inhibitor concentrate in pregnant women with hereditary angioedema.
- Published in:
- Allergy & Asthma Proceedings, 2017, v. 38, n. 3, p. 216, doi. 10.2500/aap.2017.38.4038
- By:
- Publication type:
- Article
Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
- Published in:
- Allergy & Asthma Proceedings, 2012, v. 33, n. 4, p. 354, doi. 10.2500/aap.2012.33.3589
- By:
- Publication type:
- Article
Interaction of Cyclophosphamide and Ketamine in vivo.
- Published in:
- Neuroimmunomodulation, 1996, v. 3, n. 6, p. 333, doi. 10.1159/000097364
- By:
- Publication type:
- Article
Pharmacokinetic Analysis of Weekly Versus Biweekly IgPro20 Dosing in Patients With Primary Immunodeficiency.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 6, p. 664, doi. 10.1002/cpdd.753
- By:
- Publication type:
- Article
Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the HILO Study.
- Published in:
- Journal of Clinical Immunology, 2021, v. 41, n. 2, p. 458, doi. 10.1007/s10875-020-00912-5
- By:
- Publication type:
- Article
Safety and Tolerability of Manual Push Administration of Subcutaneous IgPro20 at High Infusion Rates in Patients with Primary Immunodeficiency: Findings from the Manual Push Administration Cohort of the HILO Study.
- Published in:
- Journal of Clinical Immunology, 2021, v. 41, n. 1, p. 66, doi. 10.1007/s10875-020-00876-6
- By:
- Publication type:
- Article
Treatment Satisfaction with Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency: a Pooled Analysis of Six Hizentra® Studies.
- Published in:
- Journal of Clinical Immunology, 2018, v. 38, n. 8, p. 886, doi. 10.1007/s10875-018-0562-3
- By:
- Publication type:
- Article
Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 Trials.
- Published in:
- Journal of Clinical Immunology, 2018, v. 38, n. 8, p. 864, doi. 10.1007/s10875-018-0560-5
- By:
- Publication type:
- Article
Quantitative Evidence of Wear-Off Effect at the End of the Intravenous IgG (IVIG) Dosing Cycle in Primary Immunodeficiency.
- Published in:
- Journal of Clinical Immunology, 2016, v. 36, n. 3, p. 210, doi. 10.1007/s10875-016-0243-z
- By:
- Publication type:
- Article
Clinical Experience With an L-Proline-Stabilized 10 % Intravenous Immunoglobulin (Privigen®): Real-Life Effectiveness and Tolerability.
- Published in:
- Journal of Clinical Immunology, 2014, v. 34, n. 7, p. 804, doi. 10.1007/s10875-014-0070-z
- By:
- Publication type:
- Article
Erratum to: Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases.
- Published in:
- 2014
- By:
- Publication type:
- Erratum
Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases.
- Published in:
- Journal of Clinical Immunology, 2014, v. 34, n. 2, p. 204, doi. 10.1007/s10875-013-9985-z
- By:
- Publication type:
- Article
Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency.
- Published in:
- Journal of Clinical Immunology, 2010, v. 30, n. 5, p. 734, doi. 10.1007/s10875-010-9423-4
- By:
- Publication type:
- Article
Tolerability of a New 10% Liquid Immunoglobulin for Intravenous Use, Privigen®, at Different Infusion Rates.
- Published in:
- Journal of Clinical Immunology, 2010, v. 30, n. 3, p. 442, doi. 10.1007/s10875-010-9373-x
- By:
- Publication type:
- Article
Pharmacokinetics of Subcutaneous IgPro20 in Patients with Primary Immunodeficiency.
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 6, p. 405, doi. 10.2165/11587030-000000000-00000
- By:
- Publication type:
- Article
Safety and tolerability of IgPro10 in Japanese primary immunodeficiency patients: a registrational study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Use of a C1 Inhibitor Concentrate in Adults ≥65 Years of Age with Hereditary Angioedema: Findings from the International Berinert (C1-INH) Registry.
- Published in:
- Drugs & Aging, 2016, v. 33, n. 11, p. 819, doi. 10.1007/s40266-016-0403-0
- By:
- Publication type:
- Article
Patients with primary immunodeficiency receiving subcutaneous immune globulin Hizentra maintain health-related quality of life and treatment satisfaction in a multicentre extension study of efficacy, tolerability and safety.
- Published in:
- Journal of Pharmaceutical Health Services Research, 2012, v. 3, n. 1, p. 41, doi. 10.1111/j.1759-8893.2011.00076.x
- By:
- Publication type:
- Article
Reactions of keratinocytes to in vitro millimeter wave exposure.
- Published in:
- Bioelectromagnetics, 2001, v. 22, n. 5, p. 358, doi. 10.1002/bem.62
- By:
- Publication type:
- Article
Effect of millimeter waves on survival of UVC-exposed Escherichia coli.
- Published in:
- Bioelectromagnetics, 1995, v. 16, n. 3, p. 188, doi. 10.1002/bem.2250160307
- By:
- Publication type:
- Article